Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Behavioural Brain Research|September 22, 2009
Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/-) mice showed no memory enhancement but hyposensitivity to amnesic drugsJulie Espallergues, Laurie Galvan, Florence Sabatier, et al.Journal of Huntington'S Disease|July 27, 2014
Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's DiseaseLaurie Galvan, Véronique M André, Elizabeth A Wang, et al.Frontiers in Synaptic Neuroscience|May 30, 2019
Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington's Disease MiceSandra M Holley, Laurie Galvan, Talia Kamdjou, et al.Plos Currents|February 26, 2013
Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington's DiseaseJane Y Chen, Elizabeth Wang, Laurie Galvan, et al.Scientific Reports|July 11, 2023
Mice prenatally exposed to valproic acid do not show autism-related disorders when fed with polyunsaturated fatty acid-enriched dietsValentine Turpin, Maud Schaffhauser, Mathieu Thabault, et al.Eneuro|July 24, 2015
Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's DiseaseSandra M Holley, Prasad R Joshi, Anna Parievsky, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 26, 2013
Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse modelsCarlos Cepeda, Laurie Galvan, Sandra M Holley, et al.Neurobiology of Aging|January 27, 2015
Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivoLaetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, et al.Human Molecular Genetics|November 16, 2014
Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's diseaseLaetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, et al.Brain : a Journal of Neurology|February 26, 2016
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's diseaseLydie Boussicault, Sandro Alves, Antonin Lamazière, et al.Pageof 3